Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the newly emergent causative agent of coronavirus disease-19 (COVID-19), has resulted in more than two million deaths worldwide since it was first detected in 2019. There is a critical global need for therapeutic intervention strategies t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakovic, Allison, Risner, Kenneth, Bhalla, Nishank, Alem, Farhang, Chang, Theresa L., Weston, Warren K., Harness, Jane A., Narayanan, Aarthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916214/
https://www.ncbi.nlm.nih.gov/pubmed/33572467
http://dx.doi.org/10.3390/v13020271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916214/
https://www.ncbi.nlm.nih.gov/pubmed/33572467
http://dx.doi.org/10.3390/v13020271

Ejemplares similares